ASIAN PAINTS LTD
Prabhudas Lilladhar
Broker Research reports: Sell reports
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05 Feb 2025 | Asian Paints |
Prabhudas Lilladhar
|
2455.60 | 2123.00 | 2275.20 (7.93%) | 13.54 |
Sell
|
||||
| 05 Feb 2025 | Torrent Power |
ICICI Securities Limited
|
1620.10 | 1165.00 | 1333.65 (21.48%) | 28.09 |
Sell
|
||||
| 05 Feb 2025 | Asian Paints |
ICICI Securities Limited
|
2455.60 | 2200.00 | 2275.20 (7.93%) | Target met |
Sell
|
CY25 - likely to be another tough year (despite favourable base)
ICICI Securities Limited
While there will be a favourable base starting from Q4FY25, Asian Paints is likely to post muted growth rates in CY25 considering: (1) The stress in urban markets is likely to continue. It has also resulted in downtrading impacting the profit pool.
|
|||
| 05 Feb 2025 | Page Industries |
Emkay
|
45860.00 | 40000.00 | 45795.15 (0.14%) | Target met |
Sell
|
Q3 beat on good margin execution; demand trends remain sluggish
Emkay
PAG’s Q3 EBITDA was 7-19% ahead of street/our estimates, largely led by 250- 370bps better margin, as topline was 1-5% lower. Revenue growth moderated to 7% (vs 11% in Q2) due to muted demand environment.
|
|||
| 04 Feb 2025 | Aarti Industries |
Prabhudas Lilladhar
|
408.60 | 411.00 | 456.00 (-10.39%) | Target met |
Sell
|
||||
| 03 Feb 2025 | Greenlam Industries |
BOB Capital Markets Ltd.
|
223.04 | 500.00 | 562.80 (-60.37%) | Target met |
Sell
|
||||
| 01 Feb 2025 | V-Mart Retail |
CD Equisearch
|
3256.20 | 2408.00 | 3397.40 (-4.16%) | 26.05 |
Sell
|
||||
| 31 Jan 2025 | Relaxo Footwears |
Motilal Oswal
|
406.25 | 425.00 | 549.45 (-26.06%) | Target met |
Sell
|
||||
| 31 Jan 2025 | Ajanta Pharma |
BOB Capital Markets Ltd.
|
2676.00 | 2288.00 | 2694.45 (-0.68%) | 14.50 |
Sell
|
||||
| 30 Jan 2025 | Tatva Chintan Pharma |
KRChoksey
|
729.50 | 761.00 | 775.95 (-5.99%) | Target met |
Sell
|
Outlook remains uncertain with lack of visibility in the key SDA segment
KRChoksey
TATVA revenue missed our estimates due to significant decline in SDA segment. EBITDA beat our estimates due to lower-than-expected cost of goods sold and operating expenses. However, Adj PAT missed our estimates significantly due to higher-than-expected depreciation, lower than expected other income.
|
|||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.